VistaGen Therapeutics’ Largest Stockholder Signs 6-Month Lock-Up Agreement – Yahoo Finance

Posted: May 3, 2017 at 4:47 pm

VistaGen Therapeutics' Largest Stockholder Signs 6-Month Lock-Up Agreement
Yahoo Finance
VistaStem Therapeutics is VistaGen's wholly owned subsidiary focused on applying human pluripotent stem cell technology, internally and with collaborators, to discover, rescue, develop and commercialize proprietary new chemical entities (NCEs ...

and more »

Read the rest here:
VistaGen Therapeutics' Largest Stockholder Signs 6-Month Lock-Up Agreement - Yahoo Finance

Related Posts

Comments are closed.

Archives